Medicine & Life Sciences
Histone Deacetylase Inhibitors
100%
Inhibitory Concentration 50
72%
Proteins
60%
Histone Deacetylases
60%
Neoplasms
46%
Phosphotransferases
46%
Uracil-DNA Glycosidase
40%
Neuraminidase
36%
Ligands
36%
quinoline
34%
Growth
34%
Hydrogen Bonding
33%
Catalytic Domain
32%
Acute Myeloid Leukemia
32%
Hydroxamic Acids
32%
Cyclin-Dependent Kinase 8
31%
In Vitro Techniques
30%
Binding Sites
29%
Histone Deacetylase 6
29%
entinostat
27%
Therapeutics
27%
Melibiose
27%
Phosphorylation
27%
hispidulin
26%
shikimate kinase
26%
Zanamivir
24%
Alzheimer Disease
24%
Pharmaceutical Preparations
24%
DNA
24%
Prostatic Neoplasms
23%
Neurodegenerative Diseases
23%
Computer Simulation
23%
Enzyme Assays
23%
Vibrio parahaemolyticus
23%
Cell Line
22%
Flavonoids
22%
Lactulose
22%
Exonucleases
21%
Drug Resistance
21%
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
21%
Protein Isoforms
21%
polyglutamine
21%
Heterografts
21%
Tubulin
20%
Colorectal Neoplasms
20%
Autophagy
19%
13-acetoxysarcocrassolide
19%
7-chloro-6-piperidin-1-ylquinoline-5,8-dione
19%
cyclohexamethylene carbamide
19%
Chemical Compounds
Protein
59%
Histone
56%
Sialidase Inhibitor
36%
Hydroxamic Acid
33%
Chidamide
28%
Drug
28%
Zanamivir
27%
Antiproliferative
26%
Hispidulin
25%
Flavonoid
23%
Growth Inhibition
19%
Benzamide
19%
Antineoplastic Agent
19%
Tyrosine
18%
Eupatin
18%
Antitumor
18%
Shikimate
18%
Western Blotting
17%
Amino-Acid Residue
16%
Ethenone
16%
Environment
16%
Kd
15%
Toxin
15%
Protodioscin
15%
Antiviral Drug
13%
Binding Site
13%
Marine Metabolite
13%
P62
13%
Memantine
13%
Crystal Structure
13%
Application
13%
Antileukemic Agent
13%
Compound Z
13%
Magnolol
13%
Pargyline
12%
Percutaneous
12%
Esterase Inhibitor
12%
Melibiose
12%
Lactulose
12%
Antileucemic
12%
Apoptotic
12%
Gemcitabine
12%
Membrane Potential
11%
Haematological
11%
Resistance
11%
Tyrosine Kinase Inhibitor
11%
Dibenzofuran
11%
Drug Target
11%
50 Percent Growth Inhibition
10%